Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Gorilla and King Portfolio Candidates -- Ignore unavailable to you. Want to Upgrade?

To: StockHawk who wrote (14005)	1/3/2000 5:51:00 PM
From: 100cfm	Respond to of 54805

Stock Hawk thanks for that post. 100

To: StockHawk who wrote (14005)	1/3/2000 7:33:00 PM
From: unclewest	Respond to of 54805

By Herb Greenberg Senior Columnist 7/30/99 6:30 AM ET So, an item here yesterday questioned whether Cree Research (CREE:Nasdaq) would be able to continue to get 20% of its revs from C3 (CTHR:Nasdaq), which makes fake diamonds made of moissanite. Cree sells silicon carbide crystals to C3, which uses them to make the fake gems, and C3's sales growth lately has paled compared with its own estimates. A Cree spokeswoman wasn't available at the time, but she called yesterday with what seems, on the surface, to be a simple answer: Cree will get 20% of its revs from C3 because C3 has a sales agreement with Cree that requires C3 to buy all of Cree's silicon carbide crystal production through next June. i think herb blew that call. cree's revenues increased 60% and earnings 100% since he wrote that in july. biz.yahoo.com